logo
Sign in

BVNRY Stock Price, Chart, Stats & News

Bavarian Nordic A/S (BVNRY) does not currently pay a dividend.

2.21B
Market cap
12.56x
Current P/E
4.97x
Forward P/E

BVNRY chart

1M
3M
1Y
5Y
Loading chart...

About

Health care
Sector
Biotechnology
Industry

Bavarian Nordic A/S is a Danish biopharmaceutical company specializing in the development, production, and global commercialization of essential, life-saving vaccines. Its marketed portfolio includes non-replicating vaccines for smallpox and monkeypox (known as IMVAMUNE, IMVANEX, and JYNNEOS), as well as human rabies protection (Rabipur/RabAvert), a tick-borne encephalitis vaccine (Encepur), and an Ebola vaccine (MVABEA). The company also boasts a robust pipeline of investigational therapies.

Similar securities

Based on sector and market capitalization

Report issue